Latest Articles

Publication Date
Robot-assisted nerve-sparing eradication of deep endometriosis using the da Vinci SP.

The evolution of nerve-sparing surgery has been supported by a growing body of literature on anatomic details, dissection techniques, and functional outcomes, suggesting that nerve-sparing surgery for deep endometriosis (DE) …

Published: Oct. 25, 2024, midnight
Feasibility of Percutaneous Radiofrequency Ablation for Abdominal Wall Endometriosis: A Prospective Pilot Study.

To assess the feasibility of percutaneous radiofrequency ablation (PRFA) of anterior abdominal wall endometriosis (AWE) lesions and to describe its efficacy on clinical symptoms and on the volume of the …

Published: Oct. 25, 2024, midnight
Five Things You Need To Know About Endometriosis - Yale School of Medicine

Five Things You Need To Know About Endometriosis Yale School of Medicine

Published: Oct. 24, 2024, 10:23 p.m.
Hope Medicine touts favourable mid-stage data for endometriosis therapy - FirstWord Pharma

Hope Medicine touts favourable mid-stage data for endometriosis therapy FirstWord Pharma

Published: Oct. 24, 2024, 9:31 p.m.
For Daisy Ridley, a Plant-Based Diet Is Key to Managing Her PCOS, Endometriosis, and Graves’ Disease - VegNews

For Daisy Ridley, a Plant-Based Diet Is Key to Managing Her PCOS, Endometriosis, and Graves’ Disease VegNews

Published: Oct. 24, 2024, 9:30 p.m.
Son of Endometriosis Patient Running NYC Marathon to Honor His Mom and Bring Awareness to the Disease - Endometriosis Foundation of America - The Blossom

Son of Endometriosis Patient Running NYC Marathon to Honor His Mom and Bring Awareness to the Disease Endometriosis Foundation of America - The Blossom

Published: Oct. 24, 2024, 7:10 p.m.
Neoadjuvant Treatment Considerations for Endometrial Cancer - Cancer Network

Neoadjuvant Treatment Considerations for Endometrial Cancer Cancer Network

Published: Oct. 24, 2024, 6:19 p.m.
Molecular Classification of Endometrial Cancer - Cancer Network

Molecular Classification of Endometrial Cancer Cancer Network

Published: Oct. 24, 2024, 6:19 p.m.
Bayer, Dewpoint to work on heart drug; Viking’s obesity manufacturing plans - Endpoints News

Bayer, Dewpoint to work on heart drug; Viking’s obesity manufacturing plans Endpoints News

Published: Oct. 24, 2024, 2:27 p.m.
Merck’s KEYTRUDA® (pembrolizumab) Receives 30th Approval From European Commission With Two New Indications in Gynecologic Cancers - BioSpace

Merck’s KEYTRUDA® (pembrolizumab) Receives 30th Approval From European Commission With Two New Indications in Gynecologic Cancers BioSpace

Published: Oct. 24, 2024, 11:46 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!